Volume 73, Issue 2, Pages (February 2018)

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy,
Volume 59, Issue 2, Pages (February 2011)
The PSA Era is not Over for Prostate Cancer
Volume 51, Issue 2, Pages (February 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 4, Issue 5, Pages (September 2017)
Testosterone Therapy in Men With Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 69, Issue 5, Pages (May 2016)
Volume 70, Issue 1, Pages (July 2016)
Prostate Cancer: Highlights from 2006
Volume 60, Issue 5, Pages (November 2011)
Volume 61, Issue 5, Pages (May 2012)
Volume 74, Issue 2, Pages (August 2018)
Volume 53, Issue 5, Pages (May 2008)
Volume 64, Issue 4, Pages (October 2013)
Volume 73, Issue 6, Pages (June 2018)
Volume 71, Issue 5, Pages (May 2017)
Prostate Cancer Epidemic in Sight?
Volume 65, Issue 6, Pages (June 2014)
Volume 72, Issue 5, Pages (November 2017)
Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer  Sam Ladjevardi, Gabriel Sandblom,
Volume 67, Issue 2, Pages (February 2015)
What is New in Hormone Therapy for Prostate Cancer in 2007?
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 68, Issue 3, Pages (September 2015)
Volume 67, Issue 3, Pages (March 2015)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 63, Issue 5, Pages (May 2013)
Volume 71, Issue 5, Pages (May 2017)
Volume 70, Issue 5, Pages (November 2016)
Nat. Rev. Urol. doi: /nrurol
Volume 73, Issue 4, Pages (April 2018)
Prostate Cancer Epidemic in Sight?
Thromboembolic Events Following Surgery for Prostate Cancer
The PSA Era is not Over for Prostate Cancer
Volume 72, Issue 5, Pages (November 2017)
Volume 61, Issue 5, Pages (May 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 61, Issue 2, Pages (February 2012)
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.
Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer  Valeria.
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
Volume 62, Issue 6, Pages (December 2012)
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial  Eva Johansson,
Volume 72, Issue 4, Pages (October 2017)
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study  Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg,
Volume 71, Issue 5, Pages (May 2017)
What's New in Prostate Cancer: Highlights from Urologic and Oncologic Congresses in 2006  Michel Soulié, Nicolas Mottet, Laurent Salomon, Jacques Irani,
European Urology Oncology
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Long-Term Hormonal Therapy: Who Would Benefit?
Volume 59, Issue 4, Pages (April 2011)
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Axel Heidenreich  European Urology Supplements 
Improving Flexibility and Quality of Life for Your Patients: A Must?
Volume 53, Issue 6, Pages (June 2008)
Volume 51, Issue 2, Pages (February 2007)
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Axel Heidenreich  European Urology Supplements 
End-to-side Somatic-to-autonomic Nerve Grafting to Restore Erectile Function and Improve Quality of Life After Radical Prostatectomy  Jeanette C. Reece,
Volume 51, Issue 5, Pages (May 2007)
European Urology Oncology
European Urology Oncology
Presentation transcript:

Volume 73, Issue 2, Pages 215-223 (February 2018) Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy  Annika Herlemann, Janet E. Cowan, Peter R. Carroll, Matthew R. Cooperberg  European Urology  Volume 73, Issue 2, Pages 215-223 (February 2018) DOI: 10.1016/j.eururo.2017.04.027 Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 1 Patient flow chart. AS=active surveillance; BT=brachytherapy; EBRT=external beam radiation therapy; CaPSURE=Cancer of the Prostate Strategic Urologic Research Endeavor; PADT=primary androgen deprivation therapy; PCa=prostate cancer; QOL=quality of life; WW=watchful waiting. European Urology 2018 73, 215-223DOI: (10.1016/j.eururo.2017.04.027) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 2 Line plot of lymph node yield by surgical approach and by year of radical prostatectomy. LN=lymph node; ORP=open radical prostatectomy; RARP=robot-assisted radical prostatectomy; RP=radical prostatectomy. European Urology 2018 73, 215-223DOI: (10.1016/j.eururo.2017.04.027) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 3 Rates of lymph node dissection (A) by clinical CAPRA score and surgical approach, (B) lymph node yield by clinical CAPRA score and surgical approach, and by (C) clinical CAPRA score and time of RARP (all p < 0.01). Median year of RARP was 2011. CAPRA=Cancer of the Prostate Risk Assessment; Int=intermediate; LNs=lymph nodes; ORP=open radical prostatectomy; RARP=robot-assisted radical prostatectomy; RP=radical prostatectomy. European Urology 2018 73, 215-223DOI: (10.1016/j.eururo.2017.04.027) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 4 Adjusted mean outcome scores from repeated measures mixed models for (A) urinary incontinence, (B) urinary bother, (C) modified sexual function, and (D) sexual bother over time by surgical approach among 1451 men in the study population. Independent variables for each of the four models for urinary incontinence, urinary bother, modified sexual function, and sexual bother included surgical approach, time, surgical approach-time interaction, patient age, and year at diagnosis, number of comorbidities, clinical Cancer of the Prostate Risk Assessment score, prostate volume, body mass index at diagnosis, degree of nerve−sparing, and surgical volume (total number of RPs per clinical site). EPIC=Expanded Prostate Cancer Index Composite; N.R.=number at risk; ORP=open radical prostatectomy; PCI=Prostate Cancer Index; Pre=baseline (before treatment); RARP=robot-assisted radical prostatectomy; RP=radical prostatectomy. European Urology 2018 73, 215-223DOI: (10.1016/j.eururo.2017.04.027) Copyright © 2017 European Association of Urology Terms and Conditions